BIO Comments on SEC Proposal to Amend the Accelerated Filer and Large Accelerated Filer Definitions
The Biotechnology Innovation Organization provided comments to the Securities and Exchange Commission on File No. S7-06-19, its proposal to amend the Accelerated Filer and Large Accelerated Filer definitions.
BIO Comments on SEC Proposal to Amend the Accelerated Filer and Large Accelerated Filer Definitions
In a recent letter, BIO applauded the Securities and Exchange Commission (SEC) for taking a proactive approach in amending its accelerated and large accelerated filer definitions.
“If adopted as proposed, these amendments will benefit startups and their investors by freeing up more capital to invest in hiring scientists and pursuing research and development. Our members strive to protect investors by keeping them informed, but the overwhelming success of the JOBS Act shows that there is little investor sentiment for a costly one-size-fits-all compliance requirement, and they are instead more concerned with our ability to attract talent and innovate.”
Read the letter here.